FRM
VIVO

Fox Run Management’s Meridian Bioscience Inc VIVO Stock Holding History

Fox Run Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-14,888
Closed -$347K – 355
2020
Q2 		$347K Buy
+14,888
New +$216K 0.46% 77
2017
Q4 		– Sell
-14,500
Closed -$207K – 943
2017
Q3 		$207K Buy
+14,500
New +$207K 0.06% 597

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fox Run Management's VIVO Position: Q3 2020 in Review

Fox Run Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2020, closing a stake of 14,888 shares — an estimated $347K sold.

Fox Run Management first reported a position in VIVO in Q3 2017 and held it in 2 quarters. The position peaked at $347K in Q2 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q3 2020.

  • Fox Run Management reported no remaining Meridian Bioscience Inc position as of Q3 2020 after selling out during the quarter.
  • Fox Run Management sold 14,888 Meridian Bioscience Inc shares in Q3 2020, an estimated $347K.
  • Fox Run Management first reported a position in Meridian Bioscience Inc in Q3 2017 and held it in 2 quarters.
  • Fox Run Management's Meridian Bioscience Inc position peaked at $347K in Q2 2020.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2020.

Based on Fox Run Management's 13F filing for Q3 2020, filed 29 Oct 2020.